1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.36%
Revenue growth above 1.5x 6617.T's 1.36%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
40.59%
Gross profit growth above 1.5x 6617.T's 0.50%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
598.26%
EBIT growth above 1.5x 6617.T's 6.76%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
384.97%
Positive operating income growth while 6617.T is negative. John Neff might view this as a competitive edge in operations.
292.56%
Net income growth above 1.5x 6617.T's 6.29%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
292.37%
EPS growth above 1.5x 6617.T's 6.77%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
292.37%
Diluted EPS growth above 1.5x 6617.T's 6.77%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.81%
OCF growth under 50% of 6617.T's 9.87%. Michael Burry might suspect questionable revenue recognition or rising costs.
2.81%
FCF growth under 50% of 6617.T's 9.87%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
23.62%
Similar 10Y revenue/share CAGR to 6617.T's 22.62%. Walter Schloss might see both firms benefiting from the same long-term demand.
67.22%
5Y revenue/share CAGR above 1.5x 6617.T's 12.10%. David Dodd would look for consistent product or market expansions fueling outperformance.
116.33%
3Y revenue/share CAGR above 1.5x 6617.T's 5.82%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1556.42%
Net income/share CAGR above 1.5x 6617.T's 200.21% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
163.94%
5Y net income/share CAGR at 50-75% of 6617.T's 323.02%. Martin Whitman might see a shortfall in operational efficiency or brand power.
158.20%
Below 50% of 6617.T's 2029.29%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
118.72%
10Y equity/share CAGR above 1.5x 6617.T's 19.45%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
43.70%
5Y equity/share CAGR above 1.5x 6617.T's 16.10%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
32.14%
3Y equity/share CAGR above 1.5x 6617.T's 16.31%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.97%
Our AR growth while 6617.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
8.23%
Inventory growth well above 6617.T's 8.13%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.15%
Asset growth above 1.5x 6617.T's 0.76%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.30%
75-90% of 6617.T's 1.61%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
12.26%
Debt growth of 12.26% while 6617.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
3.28%
R&D dropping or stable vs. 6617.T's 16.25%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-17.24%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.